INSAID variant classification and Eurofever criteria guide optimal treatment strategy in patients with TRAPS: data from the Eurofever registry (CROSBI ID 285866)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Papa, Riccardo ; Lane, Thirusha ; Minden, Kirsten ; Touitou, Isabelle ; Cantarini, Luca ; Cattalini, Marco ; Obici, Laura ; Jansson, Annette F. ; Belot, Alexandre ; Frenkel, Joost ; Anton, Jordi ; Wolska-Kusnierz, Beata ; Berendes, Rainer ; Remesal, Agustin ; Jelušić, Marija ; Hoppenreijs, Esther ; Espada, Graciela ; Nikishina, Irina ; Maggio, Maria Cristina ; Bovis, Francesca ; Masini, Marta ; Youngstein, Taryn ; Rezk, Tamer ; Papadopoulou, Charalampia ; Brogan, Paul A. ; Hawkins, Philip N. ; Woo, Patricia ; Ruperto, Nicolino ; Gattorno, Marco ; Lachmann, Helen J.
Pediatric Rheumatology International Trials Organization (PRINTO) ; EUROTRAPS ; Eurofever Project
engleski
INSAID variant classification and Eurofever criteria guide optimal treatment strategy in patients with TRAPS: data from the Eurofever registry
Anti-IL-1 drugs are the best maintenance treatment in TRAPS patients. The diagnosis of TRAPS should be considered very carefully in patients of group B not fulfilling Eurofever criteria and C, and colchicine may be preferable as first maintenance treatment.
TNF receptor-associated periodic syndrome (TRAPS) ; TNFRSF1A gene
Epub 2020 Nov 9
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
9 (2)
2021.
783-791e4
objavljeno
2213-2198
2213-2201
10.1016/j.jaip.2020.10.053
Povezanost rada
Kliničke medicinske znanosti
